ARTHROPLASTY
AAOS2019: Prophylactic course of tamsulosin 0.4mg does not reduce rate of urinary retention post-TJA
176 men scheduled for primary total hip or knee arthroplasty were randomized to begin a course of either tamsulosin 0.4mg or placebo daily five days prior to surgery, and continue until the first postoperative day. Patients were assessed for the development of postoperative urinary retention postoperatively. The purpose of this study was to determine if prophylactic tamsulosin reduced the incidence of postoperative urinary retention. Results demonstrated no significant difference between the tamsulosin group and the placebo group for the incidence of developed of postoperative urinary retention.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
